YWYongzhi Wang

Yongzhi Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yongzhi Wang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Wang

    Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

    1 shared publication
  • Brandi Watts

    Department of Biological Sciences, Southeastern Oklahoma State University, Durant, OK, 74701, USA.

    1 shared publication
  • Chong Li

    CAS, Key Lab of Mental Health, Institute of Psychology, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 101408, China

    1 shared publication
  • Er-Hu Jin

    Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.

    1 shared publication
  • Jingjie Zhao

    CAS, Key Lab of Mental Health, Institute of Psychology, Beijing 100101, China; Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

    1 shared publication
  • Li Li

    Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

    1 shared publication

Latest Publications

  • Open Access

    Depression comorbid with hyperalgesia: Different roles of neuroinflammation induced by chronic stress and hypercortisolism

    by Jingjie Zhao, Xuesong Gao, Anna Wang, Yongzhi Wang, Yi Du, Li Li, Mingzhen Li, Chong Li, Xiaoying Jin, Mei Zhao


  • Open Access

    A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs

    by Yifan Zhang, Yu Han, Yongzhi Wang, Yinfeng Zhang, Li Li, Erhu Jin, Ligang Deng, Brandi Watts, Teresa Golden, Ning Wu

    Proton magnetic resonance spectroscopy provides a non-invasive technology to study brain metabolite levels in vivo, which can be used to measure biochemical compounds or metabolite concentrations in circumscribed brain regions. Previous research has highlighted the role of glial cells in brain white matter. It has been assumed that antidepressant treatment with SSRIs not only affects neurons, but also activates glial cells. This study focused on the observation of any potential changes in the metabolite levels of the ventral prefrontal white matter in major depressive disorder (MDD) patients who have received antidepressant treatment. 17 female patients diagnosed as MDD according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria with the scores of 18 and above on the 24-item Hamilton Depression Rating Scale (HDRS) were recruited. MRS studies were performed on a 3.0 T MR system, single voxel PRESS spectroscopy with chemical-shift selective saturation water suppression. The volume of interest was localized at the bilateral ventral prefrontal white matter regions (voxel size: 2 × 2 × 2 mm3). The spectral data analysis was performed by using the instrument manufacturer supplied software. The bilateral ventral prefrontal white matter of MDD patients showed significantly lower Cho/Cr (p < 0.05) before receiving treatment. The HDRS, as the indicator of treatment response, showed a significant decrease in patients who had gone through 12 weeks treatment (p < 0.01). The bilateral Cho/Cr values of post-treatment patients were increased significantly compared to that of pre-treatment (p < 0.05). The alteration of ventral prefrontal white matter metabolite levels are likely involved in MDD pathophysiology and imply a crucial role of white matter in MDD.